[go: up one dir, main page]

ATE223204T1 - Liposomenzusammensetzung - Google Patents

Liposomenzusammensetzung

Info

Publication number
ATE223204T1
ATE223204T1 AT93908075T AT93908075T ATE223204T1 AT E223204 T1 ATE223204 T1 AT E223204T1 AT 93908075 T AT93908075 T AT 93908075T AT 93908075 T AT93908075 T AT 93908075T AT E223204 T1 ATE223204 T1 AT E223204T1
Authority
AT
Austria
Prior art keywords
liposome composition
peyer
glands
phosphatidylinositol
cholesterol
Prior art date
Application number
AT93908075T
Other languages
English (en)
Inventor
Syuji Sato
Iwao Nozawa
Katsuhiko Akiyama
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE223204T1 publication Critical patent/ATE223204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93908075T 1992-04-10 1993-04-09 Liposomenzusammensetzung ATE223204T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11802592 1992-04-10
PCT/JP1993/000460 WO1993020801A1 (en) 1992-04-10 1993-04-09 Liposome composition

Publications (1)

Publication Number Publication Date
ATE223204T1 true ATE223204T1 (de) 2002-09-15

Family

ID=14726206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908075T ATE223204T1 (de) 1992-04-10 1993-04-09 Liposomenzusammensetzung

Country Status (8)

Country Link
US (1) US5573779A (de)
EP (1) EP0728476B1 (de)
KR (1) KR100217826B1 (de)
AT (1) ATE223204T1 (de)
AU (1) AU668934B2 (de)
CA (1) CA2117769C (de)
DE (1) DE69332276T2 (de)
WO (1) WO1993020801A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos
HUP9801834A3 (en) 1995-10-12 2000-06-28 Supergen Inc Emeryville Liposome formulations of 5beta steroids
US6015576A (en) * 1997-08-29 2000-01-18 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to an antigen
AU682805B1 (en) * 1996-03-22 1997-10-16 Biosphere Technologies Inc. Method for inducing a systemic immune response to an antigen
US6117449A (en) * 1996-03-22 2000-09-12 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to a hepatitis antigen
US6207185B1 (en) * 1996-03-22 2001-03-27 Bio-Sphere Technology Method for inducing a systemic immune response to an HIV antigen
US20020136762A1 (en) * 1998-01-14 2002-09-26 See Jackie R. Method for inducing a systemic immune response to an antigen
AU4574199A (en) * 1998-06-16 2000-01-05 Jackie R. See Method for introducing a chemical agent into the systemic circulation
US6828306B2 (en) * 2000-07-31 2004-12-07 Ottawa Heart Institute Research Corporation Charged lipid compositions and methods for their use
FR2836043B1 (fr) * 2002-02-15 2004-06-04 Inst Nat Sante Rech Med Vesicules lipidiques, preparation et utilisations
US7875288B2 (en) * 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Method for treating blood coagulation disorders
CA2660310C (en) * 2006-03-30 2015-04-21 The Research Foundation Of State University Of New York Compositions of less immunogenic and long-circulating protein-lipid complexes
US20090081284A1 (en) * 2006-04-20 2009-03-26 Tokai University Educational System Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
CN102727437A (zh) * 2006-08-02 2012-10-17 牛津大学院长校长专家委员会 病毒感染的脂质体治疗
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
EP2410989A2 (de) * 2009-03-27 2012-02-01 The Chancellor, Masters and Scholars of the University of Oxford Liposome zur senkung des cholesterinspiegels
US10617640B2 (en) 2009-07-07 2020-04-14 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction
WO2013070362A1 (en) * 2011-10-06 2013-05-16 The Research Foundation Of State University Of New York Compositions and methods for immune tolerance induction
WO2013148258A1 (en) 2012-03-29 2013-10-03 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
BR112015023124A2 (pt) 2013-03-14 2017-07-18 Therabiome Llc liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal
FR3119325B1 (fr) * 2021-01-29 2023-08-11 Renault Jean Yves Compositions liposomales orales

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645444A1 (de) * 1976-10-08 1978-04-13 Karl Dr Med Theurer Verfahren zur gewinnung von oral wirksamen arzneimitteln und impfstoffen aus primaer nicht darmwirksamen praeparaten
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4952405A (en) * 1988-10-20 1990-08-28 Liposome Technology, Inc. Method of treating M. avium infection
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
EP0432693A1 (de) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Für virusinfizierte Zellen cytotoxische Liposomen
JPH03236325A (ja) * 1989-12-11 1991-10-22 Sumitomo Chem Co Ltd ウイルス感染細胞を殺傷するリポソーム
EP0640347A1 (de) * 1992-03-03 1995-03-01 Daiichi Pharmaceutical Co., Ltd. Orale impfstoffe

Also Published As

Publication number Publication date
AU668934B2 (en) 1996-05-23
EP0728476A1 (de) 1996-08-28
US5573779A (en) 1996-11-12
EP0728476B1 (de) 2002-09-04
DE69332276T2 (de) 2003-01-09
KR100217826B1 (ko) 1999-09-01
CA2117769C (en) 2003-07-22
WO1993020801A1 (en) 1993-10-28
AU3904193A (en) 1993-11-18
KR950700725A (ko) 1995-02-20
EP0728476A4 (de) 1997-09-10
CA2117769A1 (en) 1993-10-11
DE69332276D1 (de) 2002-10-10

Similar Documents

Publication Publication Date Title
ATE223204T1 (de) Liposomenzusammensetzung
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
ES2130420T3 (es) Preparado transdermico de sustancia activa.
DE58905028D1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
ES8801118A1 (es) Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
ATE65392T1 (de) In mizellulare phospholipidische partikel eingekapselte antineoplastische anthracyclinmittel.
NO304982B1 (no) Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin
DK0871476T3 (da) Tørret blodfaktorpræparat indeholdende trehalose
UA29469C2 (uk) Ліпосомальна фармацевтична композиція для внутрішньовенного введення
DK0699068T3 (da) Reduktion af liposominducerede fysiologiske bivirkninger
IT1203577B (it) Composti lipidici anfifili procedimento per la loro preparazione e loro applicazioni particolarmente in cosmesi e dermatologia
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
ES2077904T3 (es) Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas.
ES2124328T3 (es) Liposomas que contienen diacetato de clorhexidina o digluconato de clorhexidina.
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
AU586988B2 (en) Solid drug formulations and stable suspensions
GR3029581T3 (en) Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes
ZA91115B (en) Topical compositions
FR2619505B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
SG168394G (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties